Selective serotonin reuptake inhibitor escitalopram inhibits 5-HT₃ receptor currents in NCB-20 cells

Escitalopram is one of selective serotonin reuptake inhibitor antidepressants. As an S-enantiomer of citalopram, it shows better therapeutic outcome in depression and anxiety disorder treatment because it has higher selectivity for serotonin reuptake transporter than citalopram. The objective of this study was to determine the direct inhibitory effect of escitalopram on 5-hydroxytryptamine type 3 (5-HT₃) receptor currents and study its blocking mechanism to explore additional pharmacological effects of escitalopram through 5-HT₃ receptors. Using a whole-cell voltage clamp method, we recorded currents of 5-HT₃ receptors when 5-HT was applied alone or co-applied with escitalopram in cultured NCB-20 neuroblastoma cells known to express 5-HT₃ receptors. 5-HT induced currents were inhibited by escitalopram in a concentration-dependent manner. EC50 of 5-HT on 5-HT₃ receptor currents was increased by escitalopram while the maximal peak amplitude was reduced by escitalopram. The inhibitory effect of escitalopram was voltage independent. Escitalopram worked more effectively when it was co-applied with 5-HT than pre-application of escitalopram. Moreover, escitalopram showed fast association and dissociation to the open state of 5-HT₃ receptor channel with accelerating receptor desensitization. Although escitalopram accelerated 5-HT₃ receptor desensitization, it did not change the time course of desensitization recovery. These results suggest that escitalopram can inhibit 5-HT₃ receptor currents in a non-competitive manner with the mechanism of open channel blocking.

Tricyclic antidepressant amitriptyline inhibits 5-hydroxytryptamine 3 receptor currents in NCB-20 cells

Amitriptyline, a tricyclic antidepressant, is commonly used to treat depression and neuropathic pain, but its mechanism is still unclear. We tested the effect of amitriptyline on 5-hydroxytryptamine 3 (5-HT₃) receptor currents and studied its blocking mechanism because the clinical applications of amitriptyline overlapped with 5-HT₃ receptor therapeutic potentials. Using a whole-cell voltage clamp method, we recorded the currents of the 5-HT₃ receptor when 5-HT was applied alone or co-applied with amitriptyline in cultured NCB-20 neuroblastoma cells known to express 5-HT₃ receptors. To elucidate the mechanism of amitriptyline, we simulated the 5-HT₃ receptor currents using Berkeley Madonna® software and calculated the rate constants of the agonist binding and receptor transition steps. The 5-HT₃ receptor currents were inhibited by amitriptyline in a concentration-dependent, voltage-independent manner, and a competitive mode. Amitriptyline accelerated the desensitization of the 5-HT₃ receptor. When amitriptyline was applied before 5-HT treatment, the currents rose slowly until the end of 5-HT treatment. When amitriptyline was co-applied with 5-HT, currents rose and decayed rapidly. Peak current amplitudes were decreased in both applications. All macroscopic currents recorded in whole cell voltage clamping experiments were reproduced by simulation and the changes of rate constants by amitriptyline were correlated with macroscopic current recording data. These results suggest that amitriptyline blocks the 5-HT₃ receptor by close and open state blocking mechanisms, in a competitive manner. We could expand an understanding of pharmacological mechanisms of amitriptyline related to the modulation of a 5-HT₃ receptor, a potential target of neurologic and psychiatric diseases through this study.

Neurotransmisores del sistema límbico. I. Amígdala. Primera parte

Resumen Los neurotransmisores de la amígdala en el sistema límbico comprenden, entre otros, al ácido γ-aminobutírico (GABAA,B,G), el ácido glutámico (GLU) y el N-metil-D-aspartato (NMDA), así como a las monoaminas [dopamina (DA) e hidroxitriptamina (5-HT)]. El GABA es el principal neurotransmisor inhibidor. Su actividad inhibidora se bloquea, por ejemplo, por los efectos ansiolíticos de las benzodiacepinas, tanto en la amígdala como en otros centros del sistema límbico (tálamo, corteza prefrontal, hipocampo, etc.) conectados con esta estructura. Igualmente, la corteza prefrontal cerebral regula los procesos de memoria en los que esté involucrado un componente afectivo a través de conexiones inhibidoras GABAérgicas sobre el núcleo lateral (LA) de la amígdala. Al estimularse las vías córtico-amigdalinas y tálamo-amigdalinas, se produce una excitación seguida de una inhibición mediadas por receptores del GABA en el LA. Una reducción de la inhibición puede obtenerse ya sea al estimular conjuntamente ambas vías, o al estimular primero una y luego la otra vía. Ambos tipos de depresión se regulan por inhibidores presinápticos del GABAB en interneuronas del LA que conectan con el núcleo central (CE) de la amígdala, y que aparentemente llegan por una u otra vía. Este dato apoya la existencia de un ingreso monosináptico convergente de información al LA, ingreso que interviene en la respuesta a diferentes condiciones estresantes y que limita una actividad neuronal excesiva. El GLU es el principal neurotransmisor excitador. Al estimularse la amígdala durante la aversión condicionada contra ciertos sabores por este neurotransmisor, se produce una inhibición de la actividad hipotalámica procedente de vías GABAérgicas amigdalinas que van al hipotálamo. El LA es parte del circuito neural que subyace al condicionamiento pavloviano al miedo. En este circuito, el bloqueo de los receptores de NMDA glutámicos en el LA antes del entrenamiento altera el aprendizaje del condicionamiento al miedo, pero el bloqueo previo a la prueba también altera dicha expresión. Se ha visto que un bloqueo específico causa una disrupción del circuito que interviene en el aprendizaje de este condicionamiento, mas no de la consolidación en la memoria del proceso en un momento posterior al aprendizaje. La estimulación de los colículos inferiores (CI) causa un aumento significativo de los niveles de DA en la corteza prefrontal (PFC). Asimismo, el complejo basolateral de la amígdala (BLA) sirve como filtro de la información con carga negativa que promueve el escape y que asciende a estructuras más elevadas del tallo cerebral. Se ha observado que la desactivación del BLA interfiere con la activación de los egresos dopaminérgicos corticales producidos por una estimulación con carga negativa de los CI. Se ha podido demostrar que la información con carga negativa que asciende desde los CI cursa con una modulación opuesta dada por mecanismos de DA/5-HT que descienden desde la PFC. Estos procesos parecen regularse por filtros localizados en el BLA. Existe la posibilidad de que la DA proveniente del BLA module las respuestas de la DA del nucleus accumbens durante el estrés indirectamente por medio de conexiones de la primera con la corteza prefrontal medial, la cual inhibirá, por medio de la DA, la transmisión dopaminérgica de este núcleo.

Summary Neurotransmitters of the amygdala in the limbic system include, among others, γ-aminobutyric acid (GABAA,B.G), glutamic acid (GLU) and N-methyl-D-aspartate (NMDA), as well as the monoamines [dopamine (DA) and 5-hydroxytriptamine (5-HT)]. GABA is the main inhibitory neurotransmitter. Its inhibitory activity will be blocked, for example, by the anxiolytic effects of benzodiazepines both in the amygdala and in other nuclei of the limbic system (thalamus, prefrontal cortex, hippocampus, etc.) connected to this structure. Similarly, the cerebral prefrontal cortex will regulate memory and learning processes in which an affective component may be involved through GABAergic inhibitory connections reaching the lateral nucleus (LA) of the amygdala. On stimulating cortico- and thalamo-amygdalar pathways, an excitation will be produced followed by an inhibition, both of which are mediated by GABA receptors in LA. A reduction of the second inhibition may be obtained either by joint stimulation of both pathways or by stimulation of the first and then the other pathway. Both types of depression can be regulated by presynaptic inhibitors of GABAB in LA interneurons connecting with the central nucleus of the amygdala, and which apparently arrive via either the cortical or the thalamic pathway. These data support the existence of a convergent monosynaptic information input which will be active in response to different stressful conditions, and which will limit excessive neuronal activity. GLU is the main excitatory neurotransmitter. When the amygdala is excited in the course of aversive conditioning against certain flavors by this neurotransmitter, a further inhibition of hypothalamic activity will be produced arriving via GABAergic amygdalar pathways to the hypothalamus. LA is part of the neural circuit underlying pavlovian fear conditioning. In this circuit, blocking glutamate NMDA receptors in LA before training will alter acquisition of fear conditioning, but blocking this nucleus before testing will also alter such expression. Recent research has shown that blocking will cause specific disruption of the circuits participating in fear learning, and not of memory consolidation of this process some time after learning. Stimulation of the inferior colliculi (IC) will cause a significant increment of DA levels in prefrontal cortex (PFC). Likewise, the basolateral complex (BLA) of the amygdala will serve as a filter of aversive information ascending to upper structures of the brainstem. In this regard, it has been observed that deactivation of BLA will interfere with activation of cortical dopaminergic outputs produced by aversive stimulation arriving from the IC. Aversive information ascending from the IC has been shown to be modulated by DA/5-HT mechanisms descending from PFC. These processes appear to be regulated by filters located in BLA. In the same fashion, there is the possibility that DA from the basolateral amygdala may modulate responses of DA from the nucleus accumbens during stress indirectly via connections of the amygdala with the PFC, which will inhibit, again, via DA, dopaminergic transmission of the nucleus accumbens.